A H Karara

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
To infer patterns of average systemic exposure and to estimate individual exposures in phase III clinical trials of a new anxiolytic, two statistical methodologies were applied and compared: non-linear mixed-effect modelling, and a model-free approach based on quartiles of dose-normalized plasma concentrations of the drug. Although the model-based approach(More)
  • 1